Cargando…

Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis

OBJECTIVE: We conducted a meta-analysis to assess the efficacy of prophylactic human papillomavirus (HPV) vaccines against cervical cancer precursors and HPV persistent infection among Asian populations. METHODS: Randomized controlled clinical trials conducted in Asian countries were identified from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xinyu, Hao, Yubing, Wu, Beike, Jia, Xinhua, Niu, Meili, Wang, Kunbo, Li, Zhifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755181/ https://www.ncbi.nlm.nih.gov/pubmed/36532442 http://dx.doi.org/10.3389/fmicb.2022.1052324

Ejemplares similares

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination
por: Pimenta, Jeanne M, et al.
Publicado: (2013)

Involvement of Human Papillomaviruses in Cervical Cancer
por: Wang, Xuelian, et al.
Publicado: (2018)

A Long Way: History of the Prophylactic Papillomavirus Vaccine
por: Müller, Martin, et al.
Publicado: (2007)

Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries
por: Natunen, Kari, et al.
Publicado: (2011)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
por: Garbuglia, Anna Rosa, et al.
Publicado: (2020)

Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State
por: Akhatova, Ayazhan, et al.
Publicado: (2022)

Prevalence of human papillomavirus genotypes and related cervical morphological results in southern Hunan Province of China, 2018–2020: Baseline measures at a tertiary institution prior to mass human papillomavirus vaccination
por: Lan, Zhihua, et al.
Publicado: (2023)

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
por: Kohli, M, et al.
Publicado: (2007)

Co-carcinogenesis: Human Papillomaviruses, Coal Tar Derivatives, and Squamous Cell Cervical Cancer
por: Haverkos, Harry W., et al.
Publicado: (2017)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
por: Pal, Asmita, et al.
Publicado: (2020)

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Publicado: (2010)

Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
por: Jean-Pierre, Vincent, et al.
Publicado: (2021)

Potential Effects of Human Papillomavirus Type Substitution, Superinfection Exclusion and Latency on the Efficacy of the Current L1 Prophylactic Vaccines
por: Hampson, Ian N., et al.
Publicado: (2020)

Identification of Novel Long Non-coding and Circular RNAs in Human Papillomavirus-Mediated Cervical Cancer
por: Wang, Hongbo, et al.
Publicado: (2017)

Research of cervical microbiota alterations with human papillomavirus infection status and women age in Sanmenxia area of China
por: Hu, Jintao, et al.
Publicado: (2022)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study
por: Elangovan, Ramyiadarsini, et al.
Publicado: (2021)

Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening
por: Yang, Di, et al.
Publicado: (2022)

Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries
por: Ong, Sok King, et al.
Publicado: (2023)

Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population
por: Godoy-Vitorino, Filipa, et al.
Publicado: (2018)

Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer
por: ORTIZ-GUTIÉRREZ, FELIPE, et al.
Publicado: (2021)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009)

Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
por: Lu, Beibei, et al.
Publicado: (2011)

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
por: Sias, Catia, et al.
Publicado: (2020)

High Levels of Within-Host Variations of Human Papillomavirus 16 E1/E2 Genes in Invasive Cervical Cancer
por: Hirose, Yusuke, et al.
Publicado: (2020)

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009)

High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2019)

Human papillomavirus infection in women attended at a cervical cancer screening service in Natal, Brazil
por: de Medeiros Fernandes, Thales Allyrio Araújo, et al.
Publicado: (2008)

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries
por: Garland, S M, et al.
Publicado: (2018)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
por: Hampson, Ian N.
Publicado: (2022)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
por: Ährlund-Richter, Andreas, et al.
Publicado: (2019)

New Insight Into Avian Papillomavirus Ecology and Evolution From Characterization of Novel Wild Bird Papillomaviruses
por: Canuti, Marta, et al.
Publicado: (2019)

Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
por: Aponte, Maria, et al.
Publicado: (2020)

Identification of two novel papillomaviruses in belugas
por: Li, Youyou, et al.
Publicado: (2023)

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
por: Chin’ombe, Nyasha, et al.
Publicado: (2014)

Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
por: Choi, Hoon
Publicado: (2019)

Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
por: Wu, Yanhua, et al.
Publicado: (2023)

Degradation of iprodione by a novel strain Azospirillum sp. A1-3 isolated from Tibet
por: Pan, Hu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tkd3qh8fafb3lm2464miffimm5